Approval · Notice of Compliance 28674 · 2022
TORISEL: Notice of Compliance 28674
Issued July 29, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28674
- Date
- July 29, 2022
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph. Convert the Product Monograph to the new 2020 Master template. Update to the product labels to align with the Plain Language Labelling
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TORISEL | Not yet assigned | — |
Medicinal ingredients
- TEMSIROLIMUS 25 MG per ML